Health Condition 1: B92- Sequelae of leprosy
Conditions
Interventions
Intervention1: Individualized Homoeopathic medicines: Group I: Individualized homoeopathic medicines obtained after case taking will be prescribed via oral route of administration for duration of 12 m
Sponsors
Central Council for Research in Homoeopathy
Eligibility
Inclusion criteria
Inclusion criteria: Any gender aged between 18 years and 60 years. Patients will be enrolled in the study after a minimum of 1 month of completion of treatment (i.e. MDT of at least 6 months for pauci-bacillary Those who have post-leprosy ulcers, anywhere in the body.
Exclusion criteria
Exclusion criteria: Patient taking anticoagulant/antithrombotic/immunosuppressive drugs. Patients with self reported patient history of bleeding disorder, pregnant and lactating women, Self-reported chronic alcoholism, Patients with uncontrolled diabetes,peripheral neuropathy due to other than leprosy such as nerve injury, history of spina bifida, Patients on steroid treatment for reaction or neuritis or within 03 months after steroid treatment, having alcoholic neuropathy, polyneuropathy,varicose veins, vascular diseases and arteriosclerosis
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| To evaluate the effectiveness of individualized homoeopathic medicines vs. Merc sol 200 in Post Leprosy UlcersTimepoint: Assessed monthly till end of 12 months | — |
Secondary
| Measure | Time frame |
|---|---|
| To assess the change in number, location, depth and size of the Post Leprosy ulcers. To assess the changes in the sensory functions of the area adjacent to the Post Leprosy ulcers. To assess the changes in Braden scoring scale for Post Leprosy ulcers. Timepoint: Assessed monthly till end of 12 months | — |
Countries
India
Contacts
Public ContactDr Divya Taneja
Central Council for Research in Homoeopathy
Outcome results
None listed